Skip to content

Wireless Monitoring for Clinical Deterioration

Integrated Proactive Wireless Monitoring for Clinical Deterioration: A Stepped Wedge Randomized Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06644599
Acronym
i-PROTECT
Enrollment
13160
Registered
2024-10-16
Start date
2026-02-01
Completion date
2026-12-01
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inpatient Facililty Diagnoses

Keywords

inpatients, wireless monitoring, mortality, cardiopulmonary failure

Brief summary

The study evaluates whether implementing a wireless monitoring system for patients admitted to hospital wards reduces mortality and cardiopulmonary failure.

Detailed description

The trial is designed as a stepped-wedge cluster RCT. Hospital wards (which constitute clusters in this design) will be randomized to have wireless monitoring, 7 wards at a time, with each 7 wards constituting a sequence. The study consists of 5 periods of two-month sequences followed by a one-month transition time with a phased introduction of the intervention. In the first period, all wards will have no wireless monitoring. After a baseline period of 2 (+1 washout) months, the intervention (monitoring system) will be implemented in a randomly selected new sequence every 3-month period until the intervention is implemented in all sequences.

Interventions

The monitoring wireless system will continuously monitor the heart rate, oxygen saturation (SpO2), respiratory rate, and blood pressure and in selected patients electrocardiography (ECG).

Sponsors

King Abdullah International Medical Research Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Masking description

The randomization list will be maintained with a research coordinator who is not involved in this trial, and the ward allocation will remain concealed from the research and clinical teams throughout the study and will be revealed for a given sequence only 1 month before the implementation of the intervention to allow training.

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Ward level Inpatient wards, defined as wards used to manage adult inpatients. Patient level 1. Aged 14 years or older 2. Checked in as inpatient status to one of the study wards

Exclusion criteria

Ward level 1. Cardiology, pediatric, obstetric wards 2. ICUs and emergency departments 3. Operating rooms 4. Outpatient clinics 5. Daycare wards, endoscopy, outpatient procedure areas, hemodialysis units Patient level No commitment for full life support at the time of arrival to the study ward (designated as Do-Not-Resuscitate status)

Design outcomes

Primary

MeasureTime frameDescription
Composite endpoint of 30-day in-hospital mortality, cardiac arrest, requirement of vasopressor or intubation30 daysAfter hospital admission within 30 days

Secondary

MeasureTime frameDescription
Cardiac arrest30 dayscardiac arrest within 30 days of hospital admission
Requirement of vasopressorswithin 30 days of hospital admissionuse of vasopressors/inotropic support
Requirement of intubation30 daysneed for mechanical ventilation within 30 days of hospital admission
Hospital length of stay90 dayscensored at 90 days
Transfer to ICU30 daysICU admission within 30 days of hospital admission
ICU- free days30 daysin the first 30 days of hospital admission
CCRT activation30 daysCritical care response team activation within 30 days of hospital admission

Countries

Saudi Arabia

Contacts

CONTACTYaseen M Arabi, MD
arabi@mngha.med.sa018011111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026